Trade Summary

3 days ago, Reed Elizabeth E, serving as GC, GC at Travere Therapeutics, Inc. (TVTX), sold 24,250 shares at $45.06 per share, for a total transaction value of $1,092,657.00. Following this transaction, Reed Elizabeth E now holds 105,211 shares of TVTX.

This sale represents a 19.00% decrease in Reed Elizabeth E's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 4, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 6, 2026, 2 days after the trade was made.

Travere Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.